FTO and obesity disorder: In adiposity-matched, normal-weight humans, they demonstrated that carriers of the FTO “obesity-risk” rs9939609 A allele exhibit dysregulated plasma levels of the orexigenic hormone acyl-ghrelin and reduced postprandial appetite suppression.